GPCR Structure Therapeutics Inc. - American Depositary Shares
NASDAQ · Pharmaceuticals · Ver en SEC EDGAR ↗ cerrar Oct 2, 2026 10-K/10-Q Ago 6, 2026
$27,67
· % del rango de 52 semanas
· por encima del mínimo
· a alto
$25,59mínimo 52 semanas
$94,90máximo 52 semanas
Capitalización Bursátil (MRQ)
$5.91B
P/E
-34.6
BPA
$-0.80
tus insignias
Rango 52S
$26–$95
Calificación del Analista
BUY
Precio Objetivo
$106
P/E
-34.6
ROE
-12.3%
Margen de Beneficio Neto
·
Tu barra de insignias está vacía — fija una métrica en cualquier lugar de esta página.
GPCR Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$27.67
Capitalización Bursátil (MRQ)
$5.91B
P/E
-34.6
BPA
$-0.80
ROE
-12.3%
Rango 52S
$26–$95
GPCR Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
rango
barras
La granularidad de las barras se adapta al período seleccionado; pase el ratón sobre el gráfico para ver la apertura/máximo/mínimo/cierre de una barra.
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
BPA$-0.802022-12-31 → 2025-12-31
Flujo de caja libre$-226M2023-12-31 → 2025-12-31
Valoración y ratios
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
| Métrica | Tendencia a 5 años | GPCR | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| P/E | -34.6promedio 5A ≈-57.3 | ≈-57.3 | · | · | |
| P/C (MRQ) | 4.4promedio 5A ≈9.2 | ≈9.2 | 5.9 | Sobrevalorado | |
| Precio / FCF (TTM) | -26.3promedio 5A ≈-58.2 | ≈-58.2 | · | · | |
| Precio / Flujo de Caja (TTM) | -26.8promedio 5A ≈-59.3 | ≈-59.3 | · | · | |
| Price / Tangible Book (Precio / Valor Contable Tangible) | 3.9promedio 5A ≈9.2 | ≈9.2 | · | · |
La mediana de empresas comparables se calcula sobre una base estandarizada por métrica y puede no coincidir siempre con la base TTM/MRQ que se muestra para esta acción.
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
| Métrica | Tendencia a 5 años | GPCR | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| ROA | -11.3%promedio 5A ≈-20.0% | ≈-20.0% | -6.0% | Débil | |
| ROE | -12.3%promedio 5A ≈-18.0% | ≈-18.0% | -12.6% | En línea | |
| ROIC | -11.7%promedio 5A ≈-17.6% | ≈-17.6% | -8.2% | Por debajo del promedio |
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
| Métrica | Tendencia a 5 años | GPCR | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Ratio corriente (MRQ) | 20.8promedio 5A ≈22.9 | ≈22.9 | 3.4 | Liquidez sólida | |
| Quick Ratio (Ratio Rápido) | 22.9promedio 5A ≈22.1 | ≈22.1 | 2.7 | Liquidez sólida |
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
Aún no hay datos para este grupo de ratios
Aún no hay datos fundamentales para este ticker.
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
Aún no hay datos para este grupo de ratios
Aún no hay datos fundamentales para este ticker.
valor · ≈ promedio 5A · mediana sectorial · veredicto relativo a la mediana
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
Sorpresa Media
-152.9%
Próximo informe
Nov 04, 2026
| Período | Informe | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|---|
| 30 de junio de 2026 | Ago 4, 2026 | $-0.49 | $-0.41 | -20.8% |
| 31 de marzo de 2026 | May 6, 2026 | $-0.35 | $-0.35 | 1.2% |
| 31 de diciembre de 2025 | $-1.22 | $-0.47 | -157.1% | |
| 30 de septiembre de 2025 | $-1.11 | $-0.36 | -209.7% | |
| 30 de junio de 2025 | $-1.08 | $-0.28 | -283.9% | |
| 31 de marzo de 2025 | $-0.81 | $-0.23 | -246.9% |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| R&D Expense | $225M | $109M | $70M | $36M | |
| SG&A Expense | $62M | $49M | $33M | $16M | |
| Operating Expenses | $177M | $158M | $103M | $53M | |
| Operating Income | $-177M | $-158M | $-103M | $-53M | |
| Pretax Income | $-141M | $-122M | $-89M | $-51M | |
| Income Tax | $515.0K | $310.0K | $236.0K | $17.0K | |
| Net Income | $-141M | $-123M | $-90M | $-51M | |
| EPS (Basic) | $-0.80 | $-0.78 | $-0.81 | $-5.51 | |
| EPS (Diluted) | $-0.80 | $-0.78 | $-0.81 | $-5.51 | |
| Shares (Basic) | 177,596,000 | 157,922,000 | 110,198,000 | 9,584,000 | |
| Shares (Diluted) | 177,596,000 | 157,922,000 | 110,198,000 | 9,584,000 | |
| EBITDA | $-177M | $-158M | $-103M | · |
Balance general
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Cash & Equivalents | $800M | $170M | $130M | $26M | |
| Short-term Investments | $647M | $714M | $338M | $65M | |
| Prepaid Expense | $24M | $8M | $6M | $2M | |
| Current Assets | $1.57B | $891M | $474M | $93M | |
| PP&E (Net) | $7M | $3M | $3M | $1M | |
| PP&E (Gross) | $10M | $5M | $4M | $1M | |
| Accum. Depreciation | $3M | $2M | $644.0K | $349.0K | |
| Other Non-current Assets | $717.0K | $5M | $45.0K | $3M | |
| Total Assets | $1.58B | $903M | $482M | $98M | |
| Accounts Payable | $14M | $8M | $5M | $6M | |
| Current Liabilities | $63M | $36M | $25M | $13M | |
| Capital Leases | $4M | $2M | $4M | · | |
| Other Non-current Liabilities | $647.0K | $302.0K | $298.0K | · | |
| Total Liabilities | $68M | $38M | $29M | $13M | |
| Common Stock | $21.0K | $17.0K | $14.0K | $1.0K | |
| Paid-in Capital | $1.99B | $1.19B | $659M | $2M | |
| Retained Earnings | $-470M | $-329M | $-207M | $-117M | |
| AOCI | $1M | $914.0K | $521.0K | $-110.0K | |
| Stockholders' Equity | $1.52B | $865M | $453M | $-115M | |
| Liabilities + Equity | $1.58B | $903M | $482M | $98M | |
| Shares Outstanding | 212,513,000 | 171,860,000 | 139,220,000 | 10,527,000 |
Flujo de Efectivo
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Stock-based Comp | $29M | $19M | $8M | $3M | |
| Operating Cash Flow | $-222M | $-117M | $-79M | $-46M | |
| CapEx | $4M | $1M | $2M | $155.0K | |
| Investing Cash Flow | $90M | $-359M | $-268M | $-62M | |
| Stock Issued | · | $515M | · | · | |
| Net Stock Activity | · | $515M | · | · | |
| Financing Cash Flow | $763M | $515M | $452M | $29M | |
| Net Change in Cash | $630M | $40M | $104M | $-79M | |
| Taxes Paid | $634.0K | $370.0K | $12.0K | · | |
| Free Cash Flow | $-226M | $-118M | $-82M | · |
Rentabilidad
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| ROA | -11.3% | -17.7% | -30.9% | · | |
| ROE | -12.3% | -13.9% | -27.8% | · | |
| ROIC | -11.7% | -18.3% | -22.8% | · |
Liquidez y Solvencia
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Current Ratio | 24.8 | 24.7 | 19.1 | · | |
| Quick Ratio | 22.9 | 24.5 | 18.9 | · |
Por Acción
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Book Value / Share | $7.14 | $5.03 | $3.25 | · | |
| Cash Flow / Share | $-1.25 | $-0.74 | $-0.72 | · | |
| Cash / Share | $3.76 | $0.99 | $0.93 | · | |
| EPS (TTM) | $-0.80 | $-0.78 | $-0.81 | $-5.51 |
Valoración (TTM)
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Net Income TTM | $-141M | $-123M | $-90M | $-51M | |
| Market Cap | $14.78B | $4.66B | $5.67B | · | |
| P/E | -86.9 | -34.8 | -50.3 | · | |
| P/B | 9.7 | 5.4 | 12.5 | · | |
| P / Tangible Book | 9.7 | 5.4 | 12.5 | · | |
| P / Cash Flow | -66.5 | -40.0 | -71.4 | · | |
| P / FCF | -65.5 | -39.5 | -69.5 | · | |
| Earnings Yield | -1.1% | -2.9% | -2.0% | · |
Estado de resultados
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $100M | $67M | $69M | $59M | $55M | $43M | $33M | $33M | $22M | $21M | $18M | $19M | $13M | $8M | $9M | $10M | |
| SG&A Expense | $19M | $23M | $18M | $15M | $16M | $13M | $14M | $13M | $11M | $11M | $9M | $7M | $7M | $5M | $4M | $4M | |
| Operating Expenses | $119M | $89M | $-24M | $74M | $70M | $56M | $47M | $46M | $33M | $32M | $26M | $26M | $20M | $13M | $13M | $14M | |
| Operating Income | $-119M | $-89M | $24M | $-74M | $-70M | $-56M | $-47M | $-46M | $-33M | $-32M | $-26M | $-26M | $-20M | $-13M | $-13M | $-14M | |
| Pretax Income | $-106M | $-76M | $33M | $-66M | $-62M | $-47M | $-36M | $-34M | $-26M | $-26M | $-23M | $-23M | $-18M | $-12M | $-12M | $-14M | |
| Income Tax | $234.0K | $190.0K | $170.0K | $108.0K | $139.0K | $98.0K | $136.0K | $92.0K | $53.0K | $29.0K | $405.0K | $118.0K | $25.0K | $-180.0K | $73.0K | $64.0K | |
| Net Income | $-106M | $-76M | $33M | $-66M | $-62M | $-47M | $-36M | $-34M | $-26M | $-26M | $-24M | $-23M | $-18M | $-12M | $-12M | $-14M | |
| EPS (Basic) | $-0.49 | $-0.35 | $0.20 | $-0.37 | $-0.36 | $-0.27 | $-0.21 | $-0.20 | $-0.18 | $-0.19 | $-0.21 | $-0.20 | $-0.25 | $-1.16 | $-1.27 | $-1.64 | |
| EPS (Diluted) | $-0.49 | $-0.35 | $0.20 | $-0.37 | $-0.36 | $-0.27 | $-0.21 | $-0.20 | $-0.18 | $-0.19 | $-0.21 | $-0.20 | $-0.25 | $-1.16 | $-1.27 | $-1.64 | |
| Shares (Basic) | 217,957,000 | 217,326,000 | · | 175,469,000 | 172,647,000 | 172,051,000 | · | 171,630,000 | 148,239,000 | 139,710,000 | 114,948,000 | 114,759,000 | 71,655,000 | · | 9,780,000 | 9,435,000 | |
| Shares (Diluted) | 217,957,000 | 217,326,000 | · | 175,469,000 | 172,647,000 | 172,051,000 | · | 171,630,000 | 148,239,000 | 139,710,000 | 114,948,000 | 114,759,000 | 71,655,000 | · | 9,780,000 | 9,435,000 | |
| EBITDA | $-119M | $-89M | · | $-74M | $-70M | $-56M | · | $-46M | $-33M | $-32M | $-26M | $-26M | $-20M | · | · | · |
Balance general
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $273M | $316M | $800M | $103M | $147M | $152M | $170M | $172M | $382M | $98M | $51M | $41M | $126M | $26M | · | · | |
| Short-term Investments | $1.07B | $1.14B | $647M | $696M | $639M | $685M | $714M | $743M | $545M | $339M | $155M | $184M | $114M | $65M | · | · | |
| Prepaid Expense | $29M | $32M | $24M | $15M | $13M | $13M | $8M | $8M | $11M | $13M | $5M | $4M | $5M | $2M | · | · | |
| Current Assets | $1.37B | $1.49B | $1.57B | $814M | $799M | $850M | $891M | $924M | $938M | $449M | $210M | $228M | $246M | $93M | · | · | |
| PP&E (Net) | $6M | $6M | $7M | $5M | $3M | $4M | $3M | $4M | $3M | $3M | $2M | $1M | $961.0K | $1M | · | · | |
| PP&E (Gross) | · | · | $10M | · | · | · | $5M | $5M | $4M | $4M | $3M | $2M | $1M | $1M | · | · | |
| Accum. Depreciation | · | · | $3M | · | · | · | $2M | $1M | $1M | $866.0K | $572.0K | $493.0K | $419.0K | $349.0K | · | · | |
| Other Non-current Assets | $41M | $6M | $717.0K | $7M | $6M | $6M | $5M | $2M | $2M | $47.0K | $350.0K | $38.0K | $59.0K | $3M | · | · | |
| Total Assets | $1.43B | $1.51B | $1.58B | $832M | $816M | $867M | $903M | $933M | $947M | $457M | $216M | $229M | $247M | $98M | · | · | |
| Accounts Payable | $11M | $8M | $14M | $18M | $9M | $9M | $8M | $8M | $2M | $7M | $3M | $6M | $5M | $6M | · | · | |
| Current Liabilities | $66M | $57M | $63M | $58M | $39M | $36M | $36M | $33M | $23M | $24M | $20M | $15M | $11M | $13M | · | · | |
| Capital Leases | $4M | $3M | $4M | $4M | $5M | $5M | $2M | $3M | $3M | $4M | $3M | · | · | · | · | · | |
| Other Non-current Liabilities | $1M | $863.0K | $647.0K | $325.0K | $317.0K | $308.0K | $302.0K | $309.0K | $293.0K | $296.0K | $281.0K | · | · | · | · | · | |
| Total Liabilities | $71M | $61M | $68M | $62M | $44M | $42M | $38M | $36M | $26M | $27M | $23M | $15M | $11M | $13M | · | · | |
| Common Stock | $21.0K | $21.0K | $21.0K | $18.0K | $17.0K | $17.0K | $17.0K | $17.0K | $17.0K | $14.0K | · | · | $11.0K | $1.0K | · | · | |
| Paid-in Capital | $2.01B | $2.00B | $1.99B | $1.27B | $1.21B | $1.20B | $1.19B | $1.19B | $1.18B | $663M | $375M | $373M | $371M | $2M | · | · | |
| Retained Earnings | $-652M | $-546M | $-470M | $-503M | $-438M | $-376M | $-329M | $-293M | $-259M | $-233M | $-182M | $-158M | $-135M | $-117M | · | · | |
| AOCI | $-3M | $-2M | $1M | $825.0K | $362.0K | $815.0K | $914.0K | $3M | $-487.0K | $-90.0K | $-310.0K | $-390.0K | $147.0K | $-110.0K | · | · | |
| Stockholders' Equity | $1.35B | $1.45B | $1.52B | $770M | $772M | $825M | $865M | $897M | $921M | $430M | $193M | $214M | $236M | $-115M | · | · | |
| Liabilities + Equity | $1.43B | $1.51B | $1.58B | $832M | $816M | $867M | $903M | $933M | $947M | $457M | $216M | $229M | $247M | $98M | · | · | |
| Shares Outstanding | 213,655,000 | 213,208,000 | 212,513,000 | 182,033,000 | 172,700,000 | 172,610,000 | 171,860,000 | 171,762,000 | 171,589,000 | 139,855,000 | · | · | 114,730,000 | 10,527,000 | · | · |
Flujo de Efectivo
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $13M | $12M | $8M | $7M | $8M | $6M | $6M | $6M | $4M | $3M | $2M | $2M | $3M | $623.0K | $628.0K | $643.0K | |
| Operating Cash Flow | $-120M | $15M | $-64M | $-51M | $-55M | $-52M | $-36M | $-20M | $-26M | $-34M | $-21M | $-17M | $-20M | $-12M | $-10M | $-10M | |
| CapEx | $-42.0K | $1M | $1M | $2M | $232.0K | $314.0K | $16.0K | $685.0K | $427.0K | $162.0K | $820.0K | · | · | $71.0K | $72.0K | $-53.0K | |
| Investing Cash Flow | $74M | $-497M | $56M | $-49M | $49M | $34M | $33M | $-189M | $-205M | $1M | $30M | $-69M | $-49M | $10M | $-17M | $-16M | |
| Stock Issued | · | · | · | · | · | · | · | $0 | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $2M | $-2M | $705M | $56M | $517.0K | $809.0K | $615.0K | $-757.0K | $515M | $702.0K | $473.0K | $-297.0K | $170M | $-316.0K | $-259.0K | $31M | |
| Net Change in Cash | $-44M | $-483M | $697M | $-44M | $-5M | $-17M | $-3M | $-209M | $284M | $-32M | $10M | $-86M | $100M | $-2M | $-27M | $5M | |
| Free Cash Flow | · | $14M | · | · | · | $-53M | · | · | · | $-34M | · | · | · | · | · | · |
Rentabilidad
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -9.5% | -6.4% | · | -7.4% | -7.0% | -7.1% | · | -5.9% | -4.4% | -7.4% | -22.1% | · | -14.5% | · | · | · | |
| ROE | -10.0% | -6.7% | · | -7.9% | -7.3% | -7.5% | · | -6.2% | -4.6% | -7.8% | -24.7% | · | -15.2% | · | · | · | |
| ROIC | -8.8% | -6.2% | · | -9.6% | -9.2% | -6.8% | · | -5.1% | -3.6% | -7.5% | -13.8% | -12.2% | -8.3% | · | · | · |
Liquidez y Solvencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 20.8 | 26.2 | · | 14.2 | 20.5 | 23.3 | · | 27.6 | 41.4 | 19.1 | 10.5 | 15.2 | 22.4 | · | · | · | |
| Quick Ratio | 20.3 | 25.6 | · | 13.9 | 20.1 | 22.9 | · | 27.4 | 40.9 | 18.5 | 10.2 | 15.0 | 21.9 | · | · | · |
Por Acción
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $6.34 | $6.79 | · | $4.23 | $4.47 | $4.78 | · | $5.22 | $5.37 | $3.07 | · | · | $2.06 | · | · | · | |
| Cash Flow / Share | · | $0.07 | · | · | · | $-0.30 | · | · | · | $-0.24 | · | · | $-0.28 | · | · | · | |
| Cash / Share | $1.28 | $1.48 | · | $0.57 | $0.85 | $0.88 | · | $1.00 | $2.22 | $0.70 | · | · | $1.10 | · | · | · | |
| EPS (TTM) | $-1.01 | $-0.88 | · | $-1.21 | $-1.04 | $-0.86 | · | $-0.72 | $-0.73 | $-0.75 | $-1.82 | $-2.88 | $-4.32 | · | · | · |
Valoración (TTM)
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-215M | $-170M | · | $-211M | $-179M | $-143M | · | $-111M | $-100M | $-98M | $-77M | $-66M | $-56M | · | · | · | |
| Market Cap | $11.47B | $10.28B | · | $5.10B | $3.58B | $2.99B | · | $7.54B | $6.74B | $5.99B | · | · | $2.73B | · | · | · | |
| P/E | -53.1 | -54.8 | · | -23.1 | -19.9 | -20.1 | · | -61.0 | -53.8 | -57.1 | -27.7 | -14.4 | -5.5 | · | · | · | |
| P/B | 8.5 | 7.1 | · | 6.6 | 4.6 | 3.6 | · | 8.4 | 7.3 | 13.9 | · | · | 11.5 | · | · | · | |
| P / Tangible Book | 8.5 | 7.1 | · | 6.6 | 4.6 | 3.6 | · | 8.4 | 7.3 | 13.9 | · | · | 11.5 | · | · | · | |
| P / Cash Flow | · | 674.6 | · | · | · | -57.2 | · | · | · | -175.9 | · | · | -134.4 | · | · | · | |
| Earnings Yield | -1.9% | -1.8% | · | -4.3% | -5.0% | -5.0% | · | -1.6% | -1.9% | -1.8% | -3.6% | -6.9% | -18.2% | · | · | · |
Período más reciente a la izquierda · valores nulos mostrados como ·
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Beneficio neto | $-141M | $-123M | $-90M | $-51M |
| EPS Diluido | $-0.80 | $-0.78 | $-0.81 | $-5.51 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Ratio corriente | 24.8 | 24.7 | 19.1 | · |
| Ratio Rápido | 22.9 | 24.5 | 18.9 | · |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Flujo de caja libre | $-226M | $-118M | $-82M | · |
Propietarios institucionales (13F) 204 declarantes · $3.6B total · A fecha de 30 de junio de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
Tenedores
204
Valor en tenencia
$3.6B
Nuevas posiciones
31
Posiciones cerradas
28
Actividad institucional — Q2 2026 vs trimestre anterior
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 31 (-8 vs trimestre anterior) | 28 (-10 vs trimestre anterior) | 75 (+4 vs trimestre anterior) | 55 (-11 vs trimestre anterior) | -4.4M |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| FMR LLC | $419 179 123 | 7 810 306 | 11,69% | Acciones |
| WELLINGTON MANAGEMENT GROUP LLP | $396 054 169 | 7 379 433 | 11,05% | Acciones |
| Avoro Capital Advisors LLC | $351 836 637 | 6 555 555 | 9,81% | Acciones |
| JANUS HENDERSON GROUP PLC | $258 260 143 | 5 354 981 | 7,20% | Acciones |
| Deep Track Capital, LP | $254 399 664 | 4 740 072 | 7,10% | Acciones |
| BVF INC/IL | $180 697 390 | 3 366 823 | 5,04% | Acciones |
| MORGAN STANLEY | $150 632 372 | 2 806 640 | 4,20% | Acciones |
| ORBIMED ADVISORS LLC | $118 578 498 | 2 209 400 | 3,31% | Acciones |
| PRINCIPAL FINANCIAL GROUP INC | $94 070 254 | 1 752 753 | 2,62% | Acciones |
| AMERICAN CENTURY COMPANIES INC | $90 282 956 | 1 682 179 | 2,52% | Acciones |
| RTW INVESTMENTS, LP | $86 274 901 | 1 607 507 | 2,41% | Acciones |
| Driehaus Capital Management LLC | $83 361 264 | 1 553 219 | 2,33% | Acciones |
| BAKER BROS. ADVISORS LP | $76 883 831 | 1 432 529 | 2,14% | Acciones |
| Casdin Capital, LLC | $63 062 250 | 1 175 000 | 1,76% | Acciones |
| DEERFIELD MANAGEMENT COMPANY, L.P. | $58 285 620 | 1 086 000 | 1,63% | Acciones |
| CAPITOLIS LIQUID GLOBAL MARKETS LLC | $55 875 837 | 1 041 100 | 1,56% | Acciones |
| Siren, L.L.C. | $46 852 139 | 872 967 | 1,31% | Acciones |
| Pacific Heights Asset Management LLC | $42 936 000 | 800 000 | 1,20% | Acciones |
| Rock Springs Capital Management LP | $34 365 813 | 640 317 | 0,96% | Acciones |
| Aberdeen Group plc | $34 344 238 | 639 915 | 0,96% | Acciones |
| FRANKLIN RESOURCES INC | $31 066 308 | 578 839 | 0,87% | Acciones |
| BANK OF AMERICA CORP /DE/ | $30 238 858 | 563 422 | 0,84% | Acciones |
| ALLIANCEBERNSTEIN L.P. | $29 484 326 | 611 708 | 0,82% | Acciones |
| BlackRock, Inc. | $27 433 368 | 511 149 | 0,77% | Acciones |
| Logos Global Management LP | $26 835 000 | 500 000 | 0,75% | Acciones |
| Parkman Healthcare Partners LLC | $26 065 426 | 485 661 | 0,73% | Acciones |
| Davern Capital Partners, LP | $23 939 987 | 446 059 | 0,67% | Acciones |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | $22 476 996 | 418 800 | 0,63% | Acciones |
| UBS Group AG | $20 340 179 | 378 986 | 0,57% | Acciones |
| DEUTSCHE BANK AG\ | $17 811 302 | 331 867 | 0,50% | Acciones |
| NEXTBio Capital Management LP | $16 771 660 | 312 496 | 0,47% | Acciones |
| Catalio Capital Management, LP | $14 842 438 | 276 550 | 0,41% | Acciones |
| MARSHALL WACE, LLP | $14 361 663 | 267 592 | 0,40% | Acciones |
| HSG Holding Ltd | $14 279 548 | 266 062 | 0,40% | Acciones |
| SEB Asset Management AB | $13 151 433 | 245 043 | 0,37% | Acciones |
| GOLDMAN SACHS GROUP INC | $13 030 539 | 242 790 | 0,36% | Acciones |
| AMERIPRISE FINANCIAL INC | $12 371 685 | 230 514 | 0,35% | Acciones |
| NATIONAL BANK OF CANADA /FI/ | $11 581 986 | 215 800 | 0,32% | Acciones |
| TWO SIGMA INVESTMENTS, LP | $10 957 053 | 204 156 | 0,31% | Acciones |
| Eversept Partners, LP | $10 535 528 | 196 302 | 0,29% | Acciones |
| Schonfeld Strategic Advisors LLC | $10 234 062 | 190 685 | 0,29% | Acciones |
| Woodline Partners LP | $8 254 875 | 153 808 | 0,23% | Acciones |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $8 218 000 | 153 119 | 0,23% | Acciones |
| ArrowMark Colorado Holdings LLC | $8 081 575 | 150 579 | 0,23% | Acciones |
| Susquehanna Portfolio Strategies, LLC | $7 994 039 | 148 948 | 0,22% | Acciones |
| CenterBook Partners LP | $7 944 770 | 148 030 | 0,22% | Acciones |
| Rhenman & Partners Asset Management AB | $7 787 517 | 145 100 | 0,22% | Acciones |
| GOLDMAN SACHS GROUP INC | $7 782 150 | 145 000 | 0,22% | Opción de compra |
| B Group, Inc. | $7 513 800 | 140 000 | 0,21% | Acciones |
| HighVista Strategies LLC | $7 019 177 | 130 784 | 0,20% | Acciones |
Informantes de la empresa 19 insiders · 10 directivos · 8 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| Raymond C Stevens | CHIEF EXECUTIVE OFFICER | 19 de marzo de 2026 A | 1 401 593 | 0 | 0 | $0 |
| Jun Yoon | CHIEF FINANCIAL OFFICER | 19 de marzo de 2026 A | 1 401 656 | 0 | 0 | $0 |
| Matthew Lang | COO & GC | 15 de abril de 2026 A | 184 614 | 0 | 0 | $0 |
| Crespo Blas Coll | CHIEF MEDICAL OFFICER | 21 de septiembre de 2026 S | 258 228 | 0 | 1 | $-144 889 |
| Xichen Lin | CHIEF SCIENTIFIC OFFICER | 1 de septiembre de 2026 S | 228 960 | 0 | 11 | $-1 472 329 |
| John Joseph Berrios | Chief Commercial Officer | 6 de agosto de 2026 A | 140 766 | 0 | 0 | $0 |
| Yingli Ma | CHIEF TECHNOLOGY OFFICER | 19 de marzo de 2026 A | 139 917 | 0 | 0 | $0 |
| Ashley Hall | Chief Development Officer | 19 de marzo de 2026 A | 155 187 | 0 | 0 | $0 |
| Mark Allen Bach | CHIEF MEDICAL OFFICER | 15 de marzo de 2024 A | 26 235 | 0 | 0 | $0 |
| Melita Sun Jung | Chief Business Officer | 7 de febrero de 2023 P | · | 0 | 0 | $0 |
| Joanne Waldstreicher | Consejero | 17 de junio de 2026 A | · | 0 | 0 | $0 |
| Angus C. Russell | Consejero | 17 de junio de 2026 A | · | 0 | 0 | $0 |
| Sharon Tetlow | Consejero | 17 de junio de 2026 A | · | 0 | 0 | $0 |
| Daniel G Welch | Consejero | 17 de junio de 2026 A | 123 508 | 0 | 0 | $0 |
| Eric Dobmeier | Consejero | 17 de junio de 2026 A | · | 0 | 0 | $0 |
| Ted W Love | Consejero | 17 de junio de 2026 A | · | 0 | 0 | $0 |
| Ramy Farid | Consejero | 7 de febrero de 2023 P | 3 260 495 | 0 | 0 | $0 |
| FMR LLC | Propietario del 10% | 22 de julio de 2026 S | 4 769 404 | 0 | 22 | $-7 057 088 |
| FIL Ltd | · | 7 de febrero de 2023 C | 624 239 | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Propiedad de ETFs Mantenido por 4 ETFs
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.
| Fondo | Ponderación | Unidades | A fecha de | Fuente |
|---|---|---|---|---|
| BBC · ETFis Series Trust I | 0,75% | 7 240 NS | 31 de julio de 2026 | N-PORT |
| IBB · iShares Trust | 0,17% | 446 155 SH | 11 de septiembre de 2026 | Diario |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,16% | 5 800 SH | 2 de octubre de 2026 | Diario |
| FFSM · FIDELITY COVINGTON TRUST | 0,15% | 47 095 NS | 31 de julio de 2026 | N-PORT |
GPCR Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
calificación · 23 analistas
COMPRA
Objetivo mediano
$101.00
+265,0%
8 34,8%
Compra fuerte
13 56,5%
Compra
2 8,7%
Mantener
0 0,0%
Venta
0 0,0%
Venta fuerte
Precio objetivo a 12 meses
15 analistas · 2026-10-02Objetivo medio $105.78 +282,3%
← Por Debajo de Todos los Objetivos
Precio Actual $27.67
Mín$70.00
Media$105.78
Máx$145.00
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
Base del ejercicio fiscal, precios al cierre del último ejercicio fiscal de cada empresa.
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| GPCR | $14.78B | -86.9 | · | · | -12.3% | · |
| AMRX | · | 57.3 | 8.1% | 2.4% | -80.0% | 36.9% |
| HRMY | $2.16B | 13.8 | 21.5% | 18.3% | 19.3% | 77.2% |
| PBH | $3.33B | 15.2 | -4.3% | 17.5% | 10.2% | 54.7% |
| TRLV | · | · | -0.45% | -10.3% | -10.4% | 60.2% |
| TRVI | $1.61B | -39.1 | · | · | -22.4% | · |
| NUVB | $3.03B | -14.9 | 699.0% | -325.3% | -60.3% | · |
| SEPN | $1.25B | -25.3 | 4174.5% | -106.4% | -12.9% | · |
| ANIP | $1.78B | 23.8 | 43.8% | 8.9% | 16.6% | · |
| LLY | · | 46.8 | 44.7% | 31.7% | 101.2% | · |
Últimas noticias Noticias recientes que mencionan a esta empresa
Structure Therapeutics (GPCR) Is A Hidden Biotech Multibagger Stock To Buy Now
Yahoo Finance · 3 meses atrás
Las acciones de Structure Therapeutics suben un 47%, pero un fondo acaba de liquidar por completo una posición de 2,6 millones de dólares
Nasdaq · 4 meses, 3 semanas atrás
Structure Therapeutics Cae 28% Este Año al Emerger una Participación de $6 Millones
Nasdaq · 6 meses, 1 semana atrás
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
Seleccione las métricas que le importan: haga clic en el + junto a cualquier fila en Fundamentales completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Fuente: SEC 10-Q presentada el Ago 6, 2026